Clinical trial · Interventional
Can MicroRNA's Predict Multicentricity in Breast Cancer?
NCT04516330CI-TRIAL-00046683completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to determine if microRNA's have role in predicting multicentricity in breast cancer. If a specific microRNA will be found to be related with multicentricity, it will help us to make appropriate decisions on the treatment of patients with multicentric breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multicentric Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| miRNA | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- unifocal breast cancer
- description
- patients having unifocal breast cancer
- interventionNames
- Genetic: miRNA
- type
- ACTIVE_COMPARATOR
- label
- multicentric breast cancer
- description
- patients having multicentric breast cancer
- interventionNames
- Genetic: miRNA
Primary outcomes (1)
- measure
- MicroRNA's in multicentric breast cancer
- timeFrame
- April 2014
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. Having breast cancer 2. Having no other malignancy 3. Female patient Exclusion Criteria: 1. Having other malignancy 2. Under 18 years old 3. Male patient
References
Publications (0)
Data not yet available
No reference posted for this study.